Antiphospholipid syndrome and adrenal insufficiency: a case-report

Authors

  • Fernando Salvador Serviço de Medicina Interna, Unidade Vila Real, Centro Hospitalar de Trás-os-Montes e Alto Douro
  • Joana Cunha Serviço de Medicina Interna, Unidade Vila Real, Centro Hospitalar de Trás-os-Montes e Alto Douro
  • Elisabete Pinelo Serviço de Medicina Interna, Unidade Vila Real, Centro Hospitalar de Trás-os-Montes e Alto Douro
  • Anabela Morais Serviço de Medicina Interna, Unidade Vila Real, Centro Hospitalar de Trás-os-Montes e Alto Douro
  • Trigo Faria Serviço de Medicina Interna, Unidade Vila Real, Centro Hospitalar de Trás-os-Montes e Alto Douro

Keywords:

Antiphospholipid Syndrome, Adrenal Insufficiency, Lupus

Abstract

Antiphospholipid syndrome (APS) is a thrombophilia disorder that
may be diagnosed alone or associated with a systemic disease.
A 58 years-old male patient diagnosed with primary APS,
presented with asthenia, vomiting and diffuse abdominal pain.
He was obtunded with hypotension, tachycardia and fever. The
following values were found: Platelets 76000/mm3, gamma-glutamyl transpeptidase 168IU/L, alkaline phosphatase 197IU/L
and gallstones were identified on abdominal ultrasound. Despite
antibiotics and an increase adrenergic support the patient got
worse. The adrenocorticotropic hormone was increased, cortisol
decreased and the abdominal CT scan showed multiple hematic
nodules in the adrenal glands. Adrenal insufficiency associated
with primary APS was diagnosed and corticosteroid begun with
excellent response. Two years later antinuclear antibodies and
anti-ds DNA were found and the diagnosis of systemic lupus
erythematosus and secondary APS was reached.
This case-report highlights the involvement of adrenal glands
by APS and the ongoing unpredictability of autoimmune diseases.

Downloads

Download data is not yet available.

References

Bijlsma J. Eular Compendium on Rhematic Diseases. London: British Medical Journal Publishing Group. 2009:280-290.

Miyakis S, Lockshim M, Atsumi T et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Throm Haemost 2006; 4:295-306.

Bauer A, The thrombophilias: well defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001; 135:367-373.

Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism – results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost. 1997; 77:444.

Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson J. Harrison’s Principles of Internal Medicine. The McGraw-Hill. 2008:2127-2148.

Pressoto F, Fornasini F, Betterle C, Federspil G, Rossato M. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. European Journal of Endocrinology2005; 153:507–514.

Uthman I, Salti I, Khamashta M. Endocrinologic manifestations of the antiphospholipid syndrome. Lupus 2006; 15:485-489.

Tuthill JI, Khamashta M. Management of antiphospholipid syndrome. J Autoimmun 2009; 33:92-98

Additional Files

Published

2013-06-28

How to Cite

1.
Salvador F, Cunha J, Pinelo E, Morais A, Faria T. Antiphospholipid syndrome and adrenal insufficiency: a case-report. RPMI [Internet]. 2013 Jun. 28 [cited 2024 Dec. 18];20(2):73-6. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1073

Issue

Section

Case Reports

Most read articles by the same author(s)